Bristol-Myers Squibb (BMY) Profit Margin History

Historical gross, operating and net quarterly profit margin for Bristol-Myers Squibb (BMY) over the last 10 years. The current net profit margin for Bristol-Myers Squibb as of March 22, 2018 is 4.85%.

Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $107.914B $20.776B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.